FEI delays implementation of new prohibited substances list

EQUESTRIAN SPORT NEWS : THE FEI (Federation Equestre Internationale) has decided to delay the implementation of its controversial…

EQUESTRIAN SPORT NEWS: THE FEI (Federation Equestre Internationale) has decided to delay the implementation of its controversial new equine prohibited substances list following adverse reaction to the vote taken in its favour at last month's general assembly in Copenhagen.

In the Danish capital, national federations voted 53-48 in favour of allowing in-competition use of certain non-steroidal anti-inflammatory drugs such as phenylbutazone (bute) from January 1st.

While groups such as the United States Equestrian Federation have welcomed the move, there has been considerable negative reaction from many western European countries, with Horse Sport Ireland and the British Equestrian Federation calling for a re-vote.

The FEI yesterday stated a resolution had been passed delaying the implementation of the new prohibited substances list and the accompanying equine anti-doping and controlled medication regulations until April 5th.

READ MORE

“This resolution has been passed in order to allow for broader debate and consultation on the policy change approved at the recent FEI General Assembly regarding the restricted use of a small number of non-steroidal anti-inflammatory drugs (NSAIDs).”

HSI chairman Joe Walsh welcomed the announcement from Lausanne, saying, “This is a pragmatic and sensible move which provides for a “cooling off period” and an opportunity to consult with National Federations and other stakeholders. However, it is clear changes are needed in this list and that the issue will not go away.”

Walsh further stated that HSI had convened a meeting of veterinary experts and those of its affiliate bodies on Monday evening to consider the new FEI prohibited substances’ list and the unanimous view of the veterinarians present was that the new list was a retrograde step for the sport. They felt that the matter needed far more consideration.

“The meeting was very constructive and everyone recognises that this is a complex area,” said Walsh. “However, it’s clear that there is substantial veterinary opinion from all around the world opposed to this list and that the matter needs to be revisited.”